AlloVir (ALVR)
9.81
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 4 Kalaris Therapeutics, For: Jun 03 Filed by: Jovan-Embiricos Morana
June 4, 2026 4:39 PM - SEC Filing
Form 4 Kalaris Therapeutics, For: Jun 03 Filed by: Ferrara Napoleone
June 4, 2026 4:36 PM - SEC Filing
Form 4 Kalaris Therapeutics, For: Jun 03 Filed by: Hallal David
June 4, 2026 4:29 PM - SEC Filing
Form 4 Kalaris Therapeutics, For: Jun 03 Filed by: AKKARAJU SRINIVAS
June 4, 2026 4:25 PM - SEC Filing
Form 4 Kalaris Therapeutics, For: Jun 03 Filed by: Dybbs Michael
June 4, 2026 4:23 PM - SEC Filing
Form 4 Kalaris Therapeutics, For: Jun 03 Filed by: ADAMIS ANTHONY P
June 4, 2026 4:23 PM - SEC Filing
Form 4 Kalaris Therapeutics, For: Jun 03 Filed by: PATTERSON LEONE D
June 4, 2026 4:19 PM - SEC Filing
Form 8-K Kalaris Therapeutics, For: Jun 03
June 4, 2026 4:07 PM - SEC Filing
Form SCHEDULE 13D/A Kalaris Therapeutics, Filed by: Samsara BioCapital, L.P.
May 22, 2026 7:48 PM - SEC Filing
Form 4 Kalaris Therapeutics, For: May 20 Filed by: Samsara BioCapital GP, LLC
May 22, 2026 7:47 PM - SEC Filing
Form 10-Q Kalaris Therapeutics, For: Mar 31
May 12, 2026 4:01 PM - SEC Filing
Form 8-K Kalaris Therapeutics, For: May 12
May 12, 2026 8:09 AM - SEC Filing
Form ARS Kalaris Therapeutics, For: Dec 31
April 24, 2026 4:28 PM - SEC Filing
Form DEFA14A Kalaris Therapeutics,
April 24, 2026 4:27 PM - SEC Filing
Form DEF 14A Kalaris Therapeutics, For: Jun 03
April 24, 2026 4:25 PM - SEC Filing
Form EFFECT Kalaris Therapeutics,
April 14, 2026 6:04 AM - SEC Filing
Form EFFECT Kalaris Therapeutics,
April 14, 2026 6:04 AM - SEC Filing
Form 424B3 Kalaris Therapeutics,
April 13, 2026 4:19 PM - SEC Filing
Form 424B3 Kalaris Therapeutics,
April 13, 2026 4:19 PM - SEC Filing
Form 8-K Kalaris Therapeutics, For: Apr 08
April 10, 2026 4:02 PM - SEC Filing
Form S-3 Kalaris Therapeutics,
April 3, 2026 4:20 PM - SEC Filing
Form S-3 Kalaris Therapeutics,
April 3, 2026 4:12 PM - SEC Filing
Form 4 Kalaris Therapeutics, For: Mar 19 Filed by: Hagen Brett R
March 23, 2026 4:05 PM - SEC Filing
Form 144 Kalaris Therapeutics, Filed by: Hagen Brett R
March 20, 2026 4:08 PM - SEC Filing
Form 4 Kalaris Therapeutics, For: Mar 19 Filed by: Oxtoby Andrew
March 20, 2026 4:05 PM - SEC Filing
Form 4 Kalaris Therapeutics, For: Mar 19 Filed by: Gall Matthew
March 20, 2026 4:05 PM - SEC Filing
Form 4 Kalaris Therapeutics, For: Mar 19 Filed by: Feinsod Matthew
March 20, 2026 4:05 PM - SEC Filing
Form S-8 Kalaris Therapeutics,
March 17, 2026 5:11 PM - SEC Filing
Form 10-K Kalaris Therapeutics, For: Dec 31
March 17, 2026 4:01 PM - SEC Filing
Form 8-K Kalaris Therapeutics, For: Mar 17
March 17, 2026 8:09 AM - SEC Filing
Full Article List